Loading the page
Loading the page
Our Story
Pranoraa Ayurveda exists to test a straightforward proposition: that a wellness company can be built on disclosure rather than persuasion, and that readers reward being told the truth.
Our story
The observation
Walk through the supplement aisle of any Indian pharmacy and read the packaging carefully. Most of it will tell you what a product contains without telling you how much. Most of it will invoke tradition without saying which text. Almost none of it will tell you who should not take it.
This is not a failure of individual companies so much as a settled convention. Proprietary blends protect margins. Vague claims survive regulatory scrutiny. Contraindications reduce conversion. Every incentive points in the same direction, and the result is a category where the consumer is asked for a great deal of faith and given very little to work with.
The question
The uncomfortable part of that question is that the answer is mostly known. Publish the formulation. Publish the reasoning. Publish the cautions at the same size as everything else. Say when the evidence is thin. Say when you do not know.
None of this is technically difficult. It is commercially inconvenient, which is a different problem, and the reason it so rarely happens.
The decision
Pranoraa Ayurveda was founded to test whether a wellness company can be built on disclosure rather than persuasion — whether a reader who is told the honest, partial, sometimes disappointing truth about an ingredient ends up trusting the company more, not less.
We think they do. We are aware this is a hypothesis rather than a certainty, and that a great deal of evidence in this industry points the other way.
The practice
It means an ingredient library where the guduchi page carries the liver-injury case reports published from 2021. It means product pages where “not suitable for” sits beside “designed for” at equal weight. It means a testimonials section that says we have no customers yet.
It also means being slower to launch than we would like, because a formulation we cannot fully explain is not one we will sell.
The hypothesis
That being told the partial, sometimes disappointing truth makes a reader trust a company more, not less.
A great deal of evidence in this industry points the other way: the companies that disclose least are frequently the ones that sell most. We are not claiming to have settled that argument. We are building the version of the company that would be worth having if the argument goes our way, and publishing enough for a reader to judge whether it has.
The name
The name draws on prana — the Sanskrit term for breath, and by extension for the vitality that animates a living thing. It is among the oldest ideas in Indian thought and one of the few that translates without much loss.
We were not looking for a name that sounded ancient. We were looking for one that pointed at the right thing: not a remedy, not a cure, but the ordinary capacity to live well, which is what preventive practice is actually concerned with.
What comes next
Now
Building the ingredient library and the Knowledge Centre, and formulating in the open.
Next
Completing the testing programme behind our first two formulations, at the partner facility now contracted to make them.
Then
Selling directly, with batch certificates of analysis published against batch codes.
Later
International supply, subject to the regulatory work each market genuinely requires.
Awaiting publication
No stage above carries a date.
A roadmap with invented timelines is the same category of claim as an invented certification, and this company has decided not to make either.
A stage gains a date here when the work behind it is committed and the date is one we would be willing to be held to.